|
|
||||||||
J Thorac Cardiovasc Surg 1997;113:777-783
© 1997 Mosby, Inc.
CARDIOPULMONARY BYPASS, |
Supported in part by American Heart Association grant 95014360.
Received for publication August 30, 1996 revisions requested Oct. 21, 1996; revisions received Nov. 14, 1996; accepted for publication Nov. 19, 1996. Address for reprints: J. William Gaynor, MD, Pediatric Cardiothoracic Surgery, Children's Hospital of Philadelphia, 34th St. and Civic Center Blvd., Philadelphia, PA 19104.
Abstract
Background: Endothelin-1 has been shown to be a mediator of pulmonary hypertension after cardiopulmonary bypass and deep hypothermic circulatory arrest. It is not known whether the mechanism is increased production of endothelin-1 or alterations in expression of endothelin-1 receptors in the lung. This study was designed to test the hypothesis that circulatory arrest increases endothelin-1 mRNA levels and endothelin-1 receptor expression in the lung. Methods and results: Twenty-four piglets (7 to 30 days old) were studied randomly either at baseline (controls, n = 12) or after cardiopulmonary bypass with 30 minutes of circulatory arrest (deep hypothermic circulatory arrest, n = 12). Lungs and pulmonary arteries were harvested immediately after hemodynamic data collection. Deep hypothermic circulatory arrest significantly increased pulmonary vascular resistance (p < 0.01). Deep hypothermic circulatory arrest also produced a significant increase in endothelin-1 mRNA levels in the pulmonary arteries (149 ± 55 pg vs 547 ± 111 pg, p = 0.007). There was no significant change in the pulmonary parenchymal endothelin-1 mRNA levels (4102 ± 379 pg vs 4623 ± 308 pg, p = 0.32). Ligand binding studies of the lung parenchyma revealed a single specific endothelin-1 binding site with an EC50 value (effective concentration causing 50% of the maximum response) of about 1 x 10-8 mol/L, consistent with the endothelin B subtype. Deep hypothermic circulatory arrest resulted in a significant increase in the number of endothelin-1 receptors in the lung (109 ± 6 fmol/mg total protein to 135 ± 9 fmol/mg total protein, p = 0.02). Conclusions: Deep hypothermic circulatory arrest increases production of endothelin-1 by the pulmonary vascular endothelium. Endothelin-1 production in the pulmonary parenchyma does not change. Expression of endothelin B receptors in the pulmonary parenchyma also increases after cardiopulmonary bypass with deep hypothermic circulatory arrest. This study supports the hypothesis that deep hypothermic circulatory arrest results in pulmonary vascular endothelial activation with increased endothelin-1 mRNA production.
This article has been cited by other articles:
![]() |
D. Langleben, S. M. Black, E. Mata-Greenwood, R. W. Dettman, R. H. Steinhorn, B. Ovadia, R. K. Fitzgerald, G. A. Ross, J. M. Bekker, S. Thelitz, et al. Clinical Relevance of Endothelin B-Mediated Vasoconstriction in Lambs With Increased Pulmonary Blood Flow * Response Circulation, April 13, 2004; 109(14): e183 - e183. [Full Text] [PDF] |
||||
![]() |
T. Nakano, H. Kado, Y. Shiokawa, K. Fukae, Y. Nishimura, K. Miyamoto, Y. Tanoue, H. Tatewaki, and N. Fusazaki The low resistance strategy for the perioperative management of the Norwood procedure Ann. Thorac. Surg., March 1, 2004; 77(3): 908 - 912. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Schulze-Neick, J. Li, J. A. Reader, L. Shekerdemian, A. N. Redington, and D. J. Penny The endothelin antagonist BQ123 reduces pulmonary vascular resistance after surgical intervention for congenital heart disease J. Thorac. Cardiovasc. Surg., September 1, 2002; 124(3): 435 - 441. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. G. Spinale The bioactive peptide endothelin causes multiple biologic responses relevant to myocardial and vascular performance after cardiac surgery J. Thorac. Cardiovasc. Surg., June 1, 2002; 123(6): 1031 - 1034. [Full Text] [PDF] |
||||
![]() |
H. A. Hennein Inflammation After Cardiopulmonary Bypass: Therapy for the Postpump Syndrome Seminars in Cardiothoracic and Vascular Anesthesia, September 1, 2001; 5(3): 236 - 255. [Abstract] [PDF] |
||||
![]() |
C. Joffs, C. A. Walker, J. W. Hendrick, D. J. Fary, D. K. Almany, J. N. Davis, A. T. Goldberg, F. A. Crawford Jr, and F. G. Spinale Endothelin receptor subtype A blockade selectively reduces pulmonary pressure after cardiopulmonary bypass J. Thorac. Cardiovasc. Surg., August 1, 2001; 122(2): 365 - 370. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Pearl, P. B. Manning, J. L. McNamara, M. M. Saucier, and D. W. Thomas Effect of modified ultrafiltration on plasma thromboxane B2, leukotriene B4, and endothelin-1 in infants undergoing cardiopulmonary bypass Ann. Thorac. Surg., October 1, 1999; 68(4): 1369 - 1375. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Petrossian, A. J. Parry, V. M. Reddy, G. P. Akkersdijk, D. M. McMullan, L. Thompson, K. D. Hendricks-Munoz, H. Hallak, F. L. Hanley, and J. R. Fineman ENDOTHELIN RECEPTOR BLOCKADE PREVENTS THE RISE IN PULMONARY VASCULAR RESISTANCE AFTER CARDIOPULMONARY BYPASS IN LAMBS WITH INCREASED PULMONARY BLOOD FLOW J. Thorac. Cardiovasc. Surg., February 1, 1999; 117(2): 314 - 323. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Bando, P. Vijay, M. W. Turrentine, T. G. Sharp, L. J. Means, G. J. Ensing, B. J. Lalone, Y. Sekine, L. Szekely, and J. W. Brown Dilutional And Modified Ultrafiltration Reduces Pulmonary Hypertension After Operations For Congenital Heart Disease: A Prospective Randomized Study J. Thorac. Cardiovasc. Surg., March 1, 1998; 115(3): 517 - 527. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |